Shanghai Yizhong Pharmaceutical Co., Ltd.

SHSE:688091 Voorraadrapport

Marktkapitalisatie: CN¥7.3b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Shanghai Yizhong Pharmaceutical Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jingsong Zhou

Algemeen directeur

CN¥1.5m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOno data
Eigendom CEO19.5%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Recent updates

There's Reason For Concern Over Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) Massive 34% Price Jump

Oct 01
There's Reason For Concern Over Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) Massive 34% Price Jump

Is Shanghai Yizhong Pharmaceutical (SHSE:688091) Using Too Much Debt?

Aug 20
Is Shanghai Yizhong Pharmaceutical (SHSE:688091) Using Too Much Debt?

What Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) P/E Is Not Telling You

Jul 24
What Shanghai Yizhong Pharmaceutical Co., Ltd.'s (SHSE:688091) P/E Is Not Telling You

Concerns Surrounding Shanghai Yizhong Pharmaceutical's (SHSE:688091) Performance

Apr 15
Concerns Surrounding Shanghai Yizhong Pharmaceutical's (SHSE:688091) Performance

Getting In Cheap On Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) Is Unlikely

Mar 29
Getting In Cheap On Shanghai Yizhong Pharmaceutical Co., Ltd. (SHSE:688091) Is Unlikely

CEO

Jingsong Zhou (56 yo)

no data

Tenure

CN¥1,481,200

Compensatie

Mr. Zhou Jingsong serves as Chairman of the Board and General Manager at Shanghai Yizhong Pharmaceutical Co., Ltd.